Search - tctmd.com

Displaying 201 - 220 of 316

Sort: Relevancy | Date

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe

May 01, 2014

News Industry News

Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function

April 10, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

News Conference News ACC 2014

Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR

L.A. McKeown

March 29, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Industry News

St. Jude Medical Announces Start of European Post-Approval Trial for Nanostim Leadless Pacemaker

March 18, 2014

News Industry News

Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

February 19, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Industry News

St. Jude Medical Announces First US Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker

February 05, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

News Daily News

La Anomalía en la Condución secundaria a la TAVR Empeora el Estado Funcional, No la Mortalidad

Jason Kahn

January 16, 2014

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

News Conference News TCT 2013

VA Medical Centers’ CART Program Improves Patient Care, Longitudinal Research

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

Presenter: Nicolas Dumonteil

October 29, 2013

Presentation TCT 2013

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

Presenter: Tamim Nazif

October 29, 2013

Advertisement

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe

Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

St. Jude Medical Announces Start of European Post-Approval Trial for Nanostim Leadless Pacemaker

Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

Survival After Septal Ablation for HOCM Similar to General Population

St. Jude Medical Announces First US Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

La Anomalía en la Condución secundaria a la TAVR Empeora el Estado Funcional, No la Mortalidad

TAVR a Viable Option for Intermediate-Risk Patients

Second-Generation TAVR Device Overcomes Issues of Current Valves

VA Medical Centers’ CART Program Improves Patient Care, Longitudinal Research

Innovation in Intervention: Perspectives from Industry

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content